by Jordana Choucair | Aug 11, 2022 | Opioid/Substance Use Disorders
New research published in the International Journal of Drug Policy found that most patients with opioid use disorder (OUD) can’t access potentially life-saving medications. According to the study, the rate of medications for OUD (MOUD) increased by 105.6 percent over...
by Jordana Choucair | Aug 10, 2022 | Opioid/Substance Use Disorders
Hawaii Governor David Ige outlined how the state plans to spend the $78 million it’s receiving from a multistate opioid settlement with pharmaceutical industry companies. Ige said state and Hawaii’s counties have agreed to spend the funds on treatment, prevention, and...
by Jordana Choucair | Aug 9, 2022 | Opioid/Substance Use Disorders
Behavioral Health News published a recap of a virtual discussion with Third Horizon Strategies Managing Director Greg Williams and CHESS CEO Hans Morefield regarding the transition to value-based care for Substance Use Disorder (SUD) treatment. “We need to find ways...
by Jordana Choucair | Aug 8, 2022 | Opioid/Substance Use Disorders
The Washington Post will host an event with Representatives Brian Fitzpatrick and Ann McLane Kuster – co-chairs of the Bipartisan Addiction and Mental Health Task Force – about their mental health legislation. The legislation is focused on easing access to mental...
by Jordana Choucair | Aug 5, 2022 | Opioid/Substance Use Disorders
Tennessee Attorney General Herbert Slatery III filed a lawsuit accusing Walgreens of creating a public nuisance by illegally selling and distributing opioids. According to Slatery, Walgreens dispensed more than 1.1 billion opioid prescriptions to the state’s 7...
by Jordana Choucair | Aug 2, 2022 | Opioid/Substance Use Disorders
West Virginia reached a $400 million tentative settlement with three drug distributors. The state’s cities and counties sued AmerisourceBergen, Cardinal Health, and McKesson for their role in fueling the opioid epidemic. If the individual cities and counties approve...
Recent Comments